Detalhe da pesquisa
1.
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
Am J Kidney Dis
; 69(5): 587-594, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889299
2.
Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study.
BMC Nephrol
; 15: 42, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24602391
3.
A single arm, prospective, open label, multicentre study for evaluation of efficacy and safety of IV CERA for treatment of chronic renal anaemia in dialysis patients not currently treated with ESA.
J Assoc Physicians India
; 62(3): 232-6, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25327065
4.
Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.
BMC Nephrol
; 14: 114, 2013 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23714169
5.
Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study.
Transpl Int
; 25(10): 1059-64, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22816557
6.
Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.
Clin J Am Soc Nephrol
; 6(2): 430-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21051752
7.
First evidence of fatal hantavirus nephropathy in India, mimicking leptospirosis.
Nephrol Dial Transplant
; 21(3): 826-7, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16361279